Bilcare

Bilcare Enterprise Value

The Enterprise Value (EV) of Bilcare (526853.BO) as of Nov 9, 2026 is 6.10 B INR. In the previous year, Enterprise Value (EV) was 7.71 B INR — a change of -20.93% (lower).

Enterprise Value

6.10 BINR

YoY

-20.93%

Last updated:

Enterprise Value (EV) of Bilcare is 2026 6.10 B INR. Enterprise Value (EV) of Bilcare was 2025 7.71 B INR. It decreases by -20.93% lower compared to the previous year.

The Bilcare Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
23.13 B INR
Jan 1, 2020
8.02 B INR
Jan 1, 2021
7.80 B INR
Jan 1, 2022
8.09 B INR
Jan 1, 2023
7.49 B INR
Jan 1, 2024
8.34 B INR
Jan 1, 2025
7.71 B INR
Jan 1, 2026
6.10 B INR
The Bilcare Enterprise Value history
YEAREnterprise ValueYoY
6.10 BINR-20.93%
7.71 BINR-7.55%
8.34 BINR+11.34%
7.49 BINR-7.44%
8.09 BINR+3.76%
7.80 BINR-2.70%
8.02 BINR-65.34%
23.13 BINR+8.87%
21.25 BINR+4.86%
20.26 BINR-5.58%
21.46 BINR-53.81%
46.45 BINR+8.97%
42.63 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bilcare Stock analysis

What does Bilcare do? Bilcare Ltd. provides pharma packaging research solutions through specialty polymer films and aluminum foils for solid-dosage pharmaceutical products. The company offers global clinical services, R&D services, and anti-counterfeit technology (nCid) as part of its product portfolio. Bilcare handles domestic and global manufacturing of investigational medicinal products (IMPs) and placebos, including primary and secondary packaging with blinding techniques, interactive Web response systems (IWRS), and temperature-controlled storage. Its clients include pharmaceutical companies requiring packaging solutions, clinical trial support, and anti-counterfeit measures for their products. The firm operates manufacturing facilities in Pune, India, with global depots spread across approximately 30+ locations worldwide. Bilcare's services target pharmaceutical manufacturers seeking packaging innovation, clinical trial management, and secure product authentication. The company leverages its presence in India, Singapore, Germany, and the United States to serve international clients needing comprehensive packaging and clinical services. Bilcare's revenue streams come from the sale of specialty polymer films, aluminum foils, and anti-counterfeit technology (nCid). The company also generates income through manufacturing IMPs and placebos, packaging services, and clinical trial support including IWRS and temperature-controlled storage. Clients primarily consist of pharmaceutical firms requiring end-to-end packaging solutions and secure clinical trial execution. Bilcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bilcare stock

Enterprise Value (EV) of Bilcare is 6.10 B INR in 2026.

Enterprise Value (EV) of Bilcare changed from 7.71 B INR to 6.10 B INR, representing a -20.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Bilcare since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Bilcare with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Bilcare

All Key Metrics — Bilcare